US20010041187A1 - Performance-enhancing dietary supplement - Google Patents

Performance-enhancing dietary supplement Download PDF

Info

Publication number
US20010041187A1
US20010041187A1 US09175748 US17574898A US2001041187A1 US 20010041187 A1 US20010041187 A1 US 20010041187A1 US 09175748 US09175748 US 09175748 US 17574898 A US17574898 A US 17574898A US 2001041187 A1 US2001041187 A1 US 2001041187A1
Authority
US
Grant status
Application
Patent type
Prior art keywords
dietary supplement
amino acids
includes
glutamine
supplement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US09175748
Inventor
Carl W Hastings
David J Barnes
Christine A Daley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Reliv' International Inc
Original Assignee
Reliv' International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A23B - A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/185Vegetable proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A23B - A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A23B - A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A23B - A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Abstract

A dietary supplement for enhancing physical performance of human subjects is disclosed. The supplement in dry, finely-divided form includes as a major ingredient a soy protein isolate containing at least 80% protein on a moisture-free basis with lesser amounts of carbohydrate, free form amino acids, medium chain triglycerides, creatine monohydrate, l-carnitine, grape seed extract, coenzyme Q10, piper nigrum extract, and alpha lipoic acid. In a preferred embodiment, the supplement also includes minor amounts of conjugated linoleic acid and phosphatidylserine/phosphatidylcholine complex.

Description

    BACKGROUND AND SUMMARY OF THE INVENTION
  • Soy protein is known to be the only plant protein equal in quality to protein derived from milk, meat or eggs. The most concentrated source of soy protein is soy protein isolate which, preferably, is manufactured by water extraction (rather than alcohol extraction) of defatted and dehulled soybeans and therefore retains its natural isoflavones. On a Protein Digestability Corrected Amino Acid Score (PDCAAS) of 1.0, soy protein isolate is highly digestible and meets or exceeds the essential amino acid requirements for children and adults. Such an isolate contains naturally high levels of branched chain amino acids to provide an energy source during physical activity, it having been reported that during the first 20 minutes of strenuous sports activity muscle glycogen serves as the primary energy source but that after 20 minutes bioavailable fatty acids and branched chain amino acids become the primary energy sources. Isolated soy protein is therefore known to be a highly desirable energy source for athletes that also helps to reduce muscle fatigue and enhance muscle recovery. [0001]
  • In addition, isolated soy protein is known to contain naturally high levels of arginine which stimulates the release of anabolic hormones to promote muscle formation, enhances wound healing, helps to maintain a strong and healthy immune system, and is believed to be beneficial in reducing stress. Such isolated soy protein is also a good source of naturally occurring iron, a fact of considerable importance for athletes who are highly susceptible to “sports anemia” resulting from loss of iron occurring in sweat and urine. [0002]
  • There is compelling evidence from both animal and human studies that, compared to animal protein, soy protein also reduces elevated levels of LDL-cholestrol. A meta-analysis of 38 clinical studies reported in 29 scientific articles has provided quantitative data showing that consumption of soy protein rather than animal protein significantly decreases blood concentrations of total cholestrol, LDLcholestrol, and triglycerides in humans. Anderson J. W., Johnstone B. M. and Cook-Newell M. E., NEJM 1995; 333:276-282. Such studies provide motivation for recommending the increased consumption of soy protein, particularly isolated soy protein, as part of an integrated dietary approach to the control of hypercholesterolemia. It is therefore believed that the intake of protein isolates may be advantageous to athletes and others concerned about the risk of developing coronary heart disease. [0003]
  • The composition of this invention is a performance-enhancing dietary supplement that contains soy protein isolate in combination with free form amino acids and also other specified components, particularly medium chain triglycerides, with the latter coacting to improve the absorption by the body of the amino acids and calcium present in the soy protein isolate and the additional amino acids included in free form in the supplement. In addition, the medium chain triglycerides produce ketone bodies that burn preferentially to muscle tissue for energy, thereby reducing muscle loss. Such medium chain triglycerides provide over twice the energy of carbohydrates (they produce 8.3 calories per gram compared to 4 calories per gram for carbohydrates) and are absorbed as quickly as glucose without significant effect on insulin production. [0004]
  • Other constituents of the dietary supplement include creatine monohydrate which helps reduce muscle fatigue and rebuild lean muscle mass, l-carnitine which is a nonprotein amino acid that acts as a biocatalyst to increase the use of fat for energy during exercise, coenzyme Q10 that, like l-carnitine, is important for its role in burning energy inside muscle cells at the mitochondria, grape seed extract and alpha lipoic acid, both of which are potent free radical scanvengers and chelators of toxic metals, and piper nigrum extract which increases the uptake of nutrients and their metabolic utilization. The supplement also preferably includes conjugated linoleic acid (CLA), a natural fatty acid that reduces body fat and increases muscle tone by helping the body extract more energy from less food, and a phosphtidylserine/phosphtidylcholine complex which functions as a cell membrane nutrient and a building block for the major membrane systems crucial to the survival and functioning of all cells. The supplement may also include one or more flavoring agents, such as vanilla extract, and processing agents such as lecithin which also lend solubility to the product. [0005]
  • The dietary supplement is provided as an essentially dry mixture in finely-divided (powdered) form with the recommended daily serving being about 26 g to about 78 g, depending on the level and intensity of physical activity involved. Individuals on an intense physical training regiment will gain optimal results at the higher levels of consumption whereas those on moderate or casual workout regimens will require less. A serving of at least 26 g per day is believed necessary to maintain optimal benefits. The powder is soluble in water and it is recommended that each daily serving be mixed with juice, water, milk, or any other drinkable non-alcoholic beverage. [0006]
  • DETAILED DESCRIPTION OF PREFERRED EMBODIMENT
  • A major ingredient of the dietary supplement of this invention is soy protein isolate containing at least 80% protein, preferably at least 90% protein, on a moisture-free basis. While alcohol extracted protein isolate may be used, it is preferred that the isolate be water extracted so that it retains its natural isoflavones. Isoflavones found naturally in soy are believed to inhibit the resorption of bone, it being noted that a synthetic isoflavone found effective in decreasing bone loss is similar in structure to soy bean isoflavones. Isolated soy protein suitable for use in the dietary supplement of this invention is commercially manufactured by water extraction of protein from defatted and dehulled soy beans and is heat treated during processing to insure inactivation of trypsin inhibitors. While isolated soy protein is commercially available from a number of sources, it is believed that a particularly effective soy protein isolate is marketed under the designation “Supro XT 12” by Protein Technologies International, St. Louis, Mo. Such isolate contains naturally high levels of branched chain amino acids as well as high levels of arginine, iron, and calcium. The essentially dry blend that constitutes the dietary supplement should contain about 55% to 70% by weight of such soy protein isolate. [0007]
  • Also included in the supplement is about 1% to 3% by weight of an amino acid premix composed of two or more free form amino acids selected from the group consisting of l-leucine, l-glutamine, l-alanine, glycine, l-arginine, l-lysine and ornithine alpha-ketogluterate. It is preferred that at least four of the free form amino acids be present in the supplement, namely, l-leucine, l-glutamine, l-alanine and glycine, and ideally all seven should be included. L-leucine is known to make up about one third of muscle protein and provides the ingredients for the manufacture of alanine and other essential biochemical components in the body, some of which are utilized for the production of energy. L-glutamine is known to promote anabolic conditions in muscle cells and increase the rate of protein synthesis. Glutamine indirectly promotes growth by increasing the hydration state of muscle cells. When cells are swollen with water, this inhibits the breakdown of protein, glycogen and glucose. Glutamine stimulates protein and glycogen synthesis. Conversely, if a cell becomes dehydrated, it shrinks and immediately goes into a catabolic state that breaks down the muscle's vital proteins. [0008]
  • L-alanine is an important source of energy for muscle tissue as well as for the brain and central nervous system. Additionally, it strengthens the immune system by producing antibodies and helps in the metabolism of sugars and organic acids. Glycine helps to trigger the release of oxygen to the energy-requiring cell-making process and is also known to be important in the manufacture of hormones responsible for a strong immune system. [0009]
  • It is known that l-arginine causes the release of growth hormones and is considered crucial for optimal muscle growth and tissue repair. It also promotes wound healing and regeneration of the liver, and studies have shown that it has improved immune responses to bacteria, viruses and tumor cells. [0010]
  • L-lysine is known to be important in insuring the adequate absorption of calcium. It also helps to form collagen and aids in the production of antibodies, hormones and enzymes. Ornithine alpha-ketoglutarate is an amino acid that improves performance in hypercatabolic states associated with such activities as vigorous sports and weightlifting. It has been noted that l-ornithine and alpha-ketoglutarate work synergistically in hypercatabolic states to achieve several favorable intermediate outcomes. Ornithine alpha-ketoglutarate reduces the rate at which ammonia accumulates. The nitrogen-sparing quality of ornithine alpha-ketoglutarate may be related to its ability to reduce the rate of glutamine loss, it being known that glutamine plays an important role in protein turnover during the catabolic states. As a result of these intermediate outcomes, ornithine alpha-ketoglutarate increases endurance, reduces muscle fatigue and shortens recovery time. In addition, it increases production of human growth hormone which in turn increases muscle mass. [0011]
  • Absorption by the body of the amino acids provided by this supplement both in free form and as branched chain amino acids in the soy protein isolate is enhanced by the inclusion of medium chain triglycerides which should be present in the amount of about 1.5% to about 2.5% by weight. Medium chain triglycerides (MCTs) are unique fatty acids that behave differently from all other fats and provide energy more like carbohydrates. They are also known as capric and caprylic fatty acids, and research studies published in medical and academic journals describe numerous benefits from the ingestion of MCTs. Of particular importance in the dietary supplement of this invention, MCTs improve the absorption of the amino acids that are critical for muscle tissue repair. They also improve the absorption of calcium, magnesium and other minerals needed for the metabolism of carbohydrates and amino acids and for improving muscle contraction response time. The MCTs therefore coact with the soy protein isolate and the free form amino acids, and with other ingredients of the supplement to improve the absorption of the amino acids. They also have a cholesterol lowering effect and are known to decrease the absorportion of cholesterol in the intestine. [0012]
  • Further, MCTs decrease the absorption of oils, fats and cholesterol while reducing muscle tissue breakdown during dieting. It has been noted that MCTs provide about twice the energy of carbohydrates and avoid the false fatigue created by eating simple sugars because, while MCTs are absorbed as quickly as glucose, they have no significant effect on insulin production. [0013]
  • The dietary supplement should include about 20% to 30% by weight of a carbohydrate, particularly fructose. The fructose not only supplies an important energy source but also renders the supplement more palatable, masking other ingredients that despite their functional importance might otherwise produce a somewhat unfavorable taste sensation for some users. If desired, the supplement may also include suitable artificial and natural flavoring agents, such as a vanilla flavoring agent, but it is to be understood that the inclusion of such agents is optional and non-critical. [0014]
  • It is known that energy consumed by muscles is largely in the form of adenosine triphosphate (ATP) and that during short-term, high intensity exercise the demand by working muscles for ATP increases to several hundred times the requirement of muscles at rest. Since ATP can be stored only to a limited extent in muscle cells, maintaining peak performance requires constant replenishment of ATP levels. The primary resupplier of ATP levels for short-duration, high intensity exercise is the amino acid creatine, about 60% of which is stored in skeletal muscle tissue in the form of creatine phosphate. During muscle contraction, creatine phosphate converts adenosine diphosphate (ADP) to ATP, thereby replacing the ATP consumed during exericse. Muscle fatigue occurs when the supply of creatine phosphate is exhausted and ADP can no longer be converted to the necessary ATP. [0015]
  • Neither creatine phosphate nor ATP can be directly supplemented in the diet; however, higher levels of creatine may be derived from creatine monohydrate, a form of creatine which has been shown to raise total plasma levels of creatine. Creatine monohydrate is therefore included in the dietary supplement of this invention to shorten the time necessary for the body to generate replacement creatine phosphate and thus significantly reduce muscle recovery time between short duration, high intensity activities. The weight percent of such creatine monohydrate in the dietary supplement should fall within the range of about 1.5% to 2.5%. [0016]
  • Recent studies have shown that athletes who supplement their diet with l-carnitine convert fat to energy more efficiently. L-carnitine is a non-protein amino acid that functions primarily in the body as a biocatalyst. Fats are burned for energy inside muscle cells at the mitochondria, but such fats are stored in adipose cells and cannot pass through the mitochondria unless they are transported by l-carnitine. Thus, the amount of fat burned depends on the level of l-carnitine in the muscle, and recent studies have indicated that athletes supplementing their diet with l-carnitine significantly increase the use of fat for energy during exercise. This dietary supplement includes l-carnitine to the extent of about 0.18% to 0.28% by weight to increase the burning of fat for energy during exercise as well as to inhibit the buildup of lactic acid in muscle, reduce muscle fatigue, decrease ketone levels in blood, and help to increase high density lipoproteins (HDL) while lowering low density lipoproteins (LDL) in the blood. [0017]
  • The dietary supplement disclosed herein also includes about 0.025% to 0.035% by weight coenzyme Q10 and about 0.01% to 0.02% by weight piper nigrum extract, the latter being commericially available under the designation “Bioperine” from Sabinsa Corporation, Piscathaway, N.J. Coenzyme Q10, first isolated from the heart muscle of cattle approximately 40 years ago, has been found to be an important component in the energy production process in cell mitochondria and more recently has been used clinically to improve the condition of patients with congestive heart failure. Through double blind studies, it has been demonstrated that the bioavailability of coenzyme Q10 is significantly increased by the co-administration of piper nigrum extract. As noted in Majeed et al U.S. Pat. No. 5,536,506, the disclosure of which is incorporated herein by reference, the metabolic pathways for a nutrient and a drug are different in that a nutrient sustains basic metabolism and physiological functions of an organism while a drug is utilized as an adjunct to basic metabolism to restore homeostasis to the physiological functions. In the context of this invention, piper nigrum extract is considered to increase the absorption of nutrients and to increase their metabolic utilization. Its inclusion in this nutritional supplement is intended to enhance the crossing-over of nutrients and botanical compounds through biological barriers such as, but not limited to, the gastrointestinal epithelium. [0018]
  • The dietary supplement also includes metabolic antioxidants in the form of grape seed extract (0.15% to 0.25% by weight) and alpha lipoic acid (0.0001% to 0.0003% by weight). Studies have shown that the biologically active flavonoids that are concentrated inside red grape seeds contain some of the most powerful antioxidants yet discovered. A particularly effective grape seed extract is commercially available under the designation “ActiVin” from Interhealth Nutritionals Inc., Concord, Calif.; the antioxidant activity of that extract has been shown to be significantly greater than that of vitamins E, C, and betacarotene, all of which are known to be powerful antioxidants that help the body fight free radicals that have been implicated in a multitude of serious health conditions. In addition, the biologically active flavonoids of the grape seed extract appear useful in helping to maintain normal blood platelet function and reduce blood platelet stickiness, thereby helping to maintain proper cardiovascular health. [0019]
  • Alpha lipoic acid is a coenzyme that participates in converting blood sugar (glucose) into energy and, in addition, is an antioxidant nutrient that networks with other antioxidants, including grape seed extract and vitamins C, E, and A, in quenching free radicals. It is understood that the other antioxidant nutrients function more effectively when there is more lipoic acid available than what is tied up in use by the body as a coenzyme. Lipoic acid is easily absorbed and is readily bioavailable. [0020]
  • In a preferred embodiment of the invention, the dietary supplement also includes conjugated linoleic acid (about 00.5% to 1.5% by weight) and a phosphatidylserine/phosphatidylcholine complex (about 0.25% to 0.35% by weight). Conjugated linoleic acid (CLA) is an essential fatty acid that reduces body fat and increases muscle tone by helping the body extract more energy from less food. While CLA is believed to be commercially available from a number of sources, one commercial product is marketed under the designation “Tonalin” by PharmaNutrients, Inc., Norway. Studies with CLA have revealed as much as a 20% reduction in body fat resulting from the ingestion of CLA, and other studies have shown that it acts as an active anti-carcinogen. [0021]
  • Phosphatidylserine/phosphatidylcholine has been referred to as a “complex” but that term is used broadly in this context to include mixtures as well as interrelated chemical structures. Phosphatidylserine is a natural soy-derived phospholipid that is known to be effective in suppressing cortisol levels. Cortisol, at the cellular level, plays an important regulatory function in the metabolism of protein, fat, carbohydrate, sodium and potassium. However, cortisol is also a catabolic stress hormone that rises in response to exercise and may interfere with training and atheletic performance by causing breakdown of muscle tissue. Therefore, phosphatidylserine may be useful to bodybuilders, powerlifters, runners, cyclists, rollers, swimmers and other high performance athletes to increase the rate of protein (muscle) synthesis during periods normally marked by muscle breakdown and to protect against the loss of amino acids, glucose, potassium and, potentially, creatine from muscle cells. It is believed to enhance the uptake of vital nutrients into muscle tissue during and after training and to accelerate muscle recovery following training. [0022]
  • Phosphatidylcholine is a cell membrane nutrient and a building block for the major membrane systems crucial to the survival and functioning of all cells. It has long been known as a nutritional supplement, but it has now been recognized for its effective benefits for liver function. In addition, when used in a nutritional supplement, it helps to replenish blood choline levels. [0023]
  • The dietary supplement optionally includes flavoring agents (0% to 3%) and a processing agent such as lecithin (0% to 3%). In the context of this invention, lecithin is considered useful primarily as a blending agent that also improves the solubility of the dietary supplement as a whole. It is commonly used in foods as an emulsifier, release agent, and instantizing agent. However, to the extent that lecithin is a complex mixture of phospholipids such as phosphatidylcholine and other substances, it is also believed to be a nutritional supplement. [0024]
  • The following examples are not intended to be limiting in any way, but demonstrate some of the preferred embodiments of the present invention.[0025]
  • EXAMPLE 1
  • A soy-based performance-enhancing dietary supplement of this invention contains the following ingredients in the percentages indicated: soy protein isolate (Supro XT12) about 61.9%, fructose 27.7%, amino acid premix (consisting of l-leucine l-glutamine, l-alanine, glycine, l-arginine, l-lysine and orinthine alpha-ketoglutarate) 2.7%, CLA (Tonalin) 0.1%, phosphatatidylserine/phosphatidylcholine complex (Corti PS 20) 0.3%, medium chain triglyceride (MCT) powder 1.9%, creatine monohydrate 1.9%, l-carnitine 0.2%, grape seed extract (ActiVin) 0.2%, coenzyme Q10 0.03%, piper nigrum extract (Bioperine) 0.01%, alpha lipoic acid 0.0002%. The supplement also includes lecithin, primarily as a blending agent, 1.3%, and flavoring agents (BBA Vanilla 14199) 1.7%. [0026]
  • Using a conventional plow blender set for continuous mixing, the fructose is first introduced into the mixing chamber with the blender in operation, and the lecithin and CLA (Tonalin) are added gradually. The choppers are then turned on for approximately 2 minutes, followed by the addition of other dry ingredients in the following sequence: Supro XT 12, amino acid premix, Corti PS 20, creatine monohydrate, MCT powder, Bioperine, ActiVin, alpha lipoic acid, coenzye Q10, l-carnitine, and flavoring agents. The choppers are again turned on for a period of an additional 2 minutes to produce a uniformly-mixed dietary supplement embodying the invention. [0027]
  • The dietary supplement prepared in accordance with this example takes the form of a fine powder to be consumed enterally as a beverage. One to three scopes (26 g to 78 g) of the powder are mixed with water, juice, milk or any other suitable beverage, and the recommend serving is then consumed once each day. [0028]
  • EXAMPLE 2
  • A dietary supplement may be prepared in accordance with Example 1 in which the amino acid premix is composed of the following ingredients and percentages (per total premix): l-glutamine 22.2%, l-arginine 22.2%, l-leucine 27.8%, l-lysine 11.1%, l-alanine 5.6%, glycine 5.6%, l-ornithine alpha-ketoglutarate 5.5% [0029]
  • EXAMPLE 3
  • A dietary supplement may be prepared in accordance with Example 1 in which amino acid premix is 1.63% by weight and consists of four amino acids in the following percentages (per total premix): l-leucine 45.4%, l-glutamine 36.4%, l-alamine 9.1%, glycine 9.1%. [0030]
  • While in the foregoing we have disclosed embodiments of the invention in considerable detail for purposes of illustration, it will be understood by those skilled in the art that many of these details may be varied without departing from the spirit and scope of the invention. [0031]

Claims (10)

  1. 1. A soy-based performance-enhancing dietary supplement comprising an essentially dry mixture of the following ingredients in a daily serving of about 26 g to 78 g: 55% to 70% soy protein isolate containing at least 80% protein on a moisture-free basis; 20% to 30% carbohydrate consisting essentially of fructose; 1% to 3% of an amino acid premix comprising two or more free form amino acids selected from the group consisting of l-leucine, l-glutamine, l-alanine, glycine, l-arginine, l-lysine and ornithine alpha-ketoglutarate; 1.5% to 2.5% medium chain triglycerides; 1.5% to 2.5% creatine monohydrate; 0.18% to 0.28% l-carnitine; 0.15% to 0.25% grape seed extract; 0.025% to 0.035% coenzyme Q10; 0.01% to 0.02% piper nigrum extract; and 0.0001% to 0.0003% alpha lipoic acid.
  2. 2. The dietary supplement of
    claim 1
    in which said amino acid premix includes the following amino acids: l-leucine, l-glutamine, l-alanine and glycine.
  3. 3. The dietary supplement of
    claim 2
    in which said amino acids are present in the following percentages per total weight of premix: l-leucine 35% to 45%, l-glutamine 30% to 40%, l-alanine 5% to 15%, glycine 5% to 15%.
  4. 4. The dietary supplement of
    claim 1
    in which said mixture also includes 0.05% to 0.15% conjugated linoleic acid.
  5. 5. The dietary supplement of claims 1, 2 or 4 in which said mixture also includes 0.25% to 0.35% phosphatidylserine/phosphatidylcholine complex.
  6. 6. The dietary supplement of claims 1, 2 or 4 in which said soy protein isolate is water extracted and includes retained isoflavones.
  7. 7. The dietary supplement of
    claim 1
    in which said amino acid premix includes all seven of said amino acids of said group.
  8. 8. The dietary supplement of
    claim 7
    in which said amino acids are present in the following percentages per total weight of premix: l-leucine 25% to 30%, l-glutamine 20% to 25%, l-alanine 4% to 7%, glycine 4% to 7%, l-arginine 20% to 25%, l-lysine 8% to 15%, ornithine alpha-ketoglutarate 4% to 7%.
  9. 9. The dietary supplement of
    claim 1
    in which said mixture also includes 0% to 3% lecithin and 0% to 3% one or more flavoring agents.
  10. 10. A soy-based performance-enhancing dietary supplement comprising an essentially dry mixture of the following ingredients in a daily serving of about 26 g to 78 g: about 61.9% soy protein isolate containing at least 80% protein on a moisture-free basis, about 27.7% carbohydrate consisting essentially of fructose, about 2.7% of an amino acid premix comprising two or more free form amino acids selected from the group consisting of l-leucine, l-glutamine, l-alanine, glycine, l-arginine, l-lysine and ornithine alpha-ketoglutarate, about 1.9% medium chain triglycerides, about 1.9% creatine monohydrate; about 0.2% l-carnitine; about 0.2% grape seed extract, about 0.1% conjugated linoleic acid, about 0.3% phosphatidylserine/phosphatidylcholine complex, about 0.03% coenzyme Q10, about 0.01% piper nigrum extract, about 0.0002% alpha lipoic acid, about 1.3% lecithin, and about 1.7% flavoring agents.
US09175748 1998-10-20 1998-10-20 Performance-enhancing dietary supplement Abandoned US20010041187A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US09175748 US20010041187A1 (en) 1998-10-20 1998-10-20 Performance-enhancing dietary supplement

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09175748 US20010041187A1 (en) 1998-10-20 1998-10-20 Performance-enhancing dietary supplement
US10781141 US8168241B2 (en) 1998-10-20 2004-02-18 Performance-enhancing dietary supplement

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10781141 Continuation US8168241B2 (en) 1998-10-20 2004-02-18 Performance-enhancing dietary supplement

Publications (1)

Publication Number Publication Date
US20010041187A1 true true US20010041187A1 (en) 2001-11-15

Family

ID=22641478

Family Applications (2)

Application Number Title Priority Date Filing Date
US09175748 Abandoned US20010041187A1 (en) 1998-10-20 1998-10-20 Performance-enhancing dietary supplement
US10781141 Active 2025-08-24 US8168241B2 (en) 1998-10-20 2004-02-18 Performance-enhancing dietary supplement

Family Applications After (1)

Application Number Title Priority Date Filing Date
US10781141 Active 2025-08-24 US8168241B2 (en) 1998-10-20 2004-02-18 Performance-enhancing dietary supplement

Country Status (1)

Country Link
US (2) US20010041187A1 (en)

Cited By (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002009534A2 (en) * 2000-07-27 2002-02-07 Sportmedizin Team Vertriebs Gmbh Diatetisches lebensmittel zum fettabbau
WO2002096218A2 (en) * 2001-05-28 2002-12-05 Basf Aktiengesellschaft Combination of lipoic acids, carnitines, and creatines in food and pharmaceuticals
WO2004017979A2 (en) * 2002-08-16 2004-03-04 Finzelberg Gmbh & Co. Kg Medicament, food supplement, and fodder additive
US20040096468A1 (en) * 2002-11-18 2004-05-20 Changaris David G. Conjugated fatty acid based emulsion and methods for preparing and using same
US20040175443A1 (en) * 1999-10-18 2004-09-09 Gardiner Paul T. Food supplement for increasing lean mass and strength
US20040197320A1 (en) * 1999-01-11 2004-10-07 Herbaceuticals Inc. Herbal supplement for increased muscle strength and endurance for athletes
WO2004089114A1 (en) * 2003-04-14 2004-10-21 Cognis Ip Management Gmbh Preparations for oral administration containing physiologically active fatty acids and oligomer proanthocyanidin
US20040229950A1 (en) * 2002-11-26 2004-11-18 Vanderhoek Jack Y. Method and composition with conjugated linoleic acid esters
US20050222050A1 (en) * 2004-03-17 2005-10-06 Nestec S.A. Compositions and methods for reducing or preventing obesity
WO2006015774A1 (en) * 2004-08-06 2006-02-16 Bioghurt Biogarde Gmbh & Co. Kg Physiologically acceptable composition containing alpha-lipoic acid, creatine, and a phosphatide
US20060045906A1 (en) * 2004-08-25 2006-03-02 Gardiner Paul T Compositions and methods for activating protein synthesis and deactivating catabolic processes in skeletal muscle
US20060251727A1 (en) * 2005-04-11 2006-11-09 Gardiner Paul T Supplemental dietary composition for increasing muscle size, strength, athletic performance and/or exercise capacity
US7169279B2 (en) 1998-09-14 2007-01-30 Applera Corporation Sample handling system for a multi-channel capillary electrophoresis device
EP1774973A1 (en) * 2005-10-12 2007-04-18 Nutricia N.V. Leucine rich composition
US20070110789A1 (en) * 2005-11-02 2007-05-17 Nestec, S. A. Isoflavone compositions for reducing accumulation of body fat in male mammals, and methods for their use
JP2007308468A (en) * 2006-05-18 2007-11-29 Bhn Kk Basal metabolism increasing agent
EP1954262A2 (en) * 2005-11-07 2008-08-13 Perque, LLC. Compositions for regulating metabolic disorders and methods of use thereof
US20090220626A1 (en) * 2005-10-06 2009-09-03 Nicogen Imc. Grape seed extract and its constituents for use as cyp2a6 inhibitors
US20100080856A1 (en) * 2008-09-26 2010-04-01 Costantino Peter D Method and composition for postoperative wound healing
EP2218342A3 (en) * 2003-05-27 2011-01-05 DSM IP Assets B.V. Novel nutraceutical compositions and use thereof
WO2011022786A1 (en) * 2009-08-31 2011-03-03 Pharmaqest Pty Ltd Methods for diagnosis and treatment of chronic fatigue syndrome
GB2479748A (en) * 2010-04-20 2011-10-26 Sis Carnitine containing nutritional composition
KR20120037145A (en) * 2010-10-11 2012-04-19 (주)아모레퍼시픽 Composition for preventing or treating obesity or hyperlipidemia containing piper longum extract, isoflavon and l-carnitin
GB2494409A (en) * 2011-09-06 2013-03-13 Ashley Mark Lawrence Vegan protein drink
CN103190630A (en) * 2013-04-19 2013-07-10 广东太阳神集团有限公司 Functional protein powder containing conjugated linoleic acid glycerides
GB2519965A (en) * 2013-11-01 2015-05-13 Readysupp Ltd Formulation
EP2926669A1 (en) 2014-04-02 2015-10-07 AlzChem AG Creatine protein matrix and method for manufacturing the same

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004043824A1 (en) * 2004-09-10 2006-03-16 Cognis Ip Management Gmbh Emulsions with unsaturated fatty acids and their esters
US20060115555A1 (en) * 2004-12-01 2006-06-01 Foulger Sidney W Nutritional supplements containing xanthone extracts
US20060115556A1 (en) * 2004-12-01 2006-06-01 Foulger Sidney W Nutritional supplement drink containing xanthone extracts
KR101275660B1 (en) 2005-05-23 2013-06-17 내츄럴 얼터너티브즈 인터내셔날, 인크. Compositions and methods for the sustained release of beta-alanine
DE102005031705A1 (en) * 2005-07-05 2007-01-18 Henkel Kgaa Compositions containing L-carnitine or L-carnitine derivatives and at least one further substance selected from taurine and its derivatives and at least one active ingredient obtainable from plants of the genus Echinacea
WO2007047041A3 (en) * 2005-10-14 2007-12-21 Hyperion Biotechnology Inc Methods and compositions for biomarkers associated with change in physical performance
US20070286909A1 (en) * 2006-06-07 2007-12-13 Daniel S. Smith Amino acid compositions
US20090110789A1 (en) * 2007-06-22 2009-04-30 Sakura Properties, Llc Antioxidant drink for dietary supplementation
US8980342B2 (en) * 2008-08-20 2015-03-17 Naturex, S.A. Antioxidant and physical performance effects of a grape extract
JP5704067B2 (en) 2009-02-27 2015-04-22 三菱瓦斯化学株式会社 Ingestible composition comprising coenzyme q10
DE102009044975A1 (en) 2009-07-23 2011-01-27 Henkel Ag & Co. Kgaa Use of carnitine and Dihydroquercetin for positively influencing the natural pigmentation process
DE102009044964A1 (en) 2009-09-24 2011-03-31 Henkel Ag & Co. Kgaa Using a combination of carnitine and / or a carnitine derivative having purine and / or a purine derivative for influencing the natural pigmentation

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3894148A (en) * 1974-03-22 1975-07-08 Vitose Corp Process for enhancing the energy metabolism of an athlete
US4832971A (en) * 1983-03-30 1989-05-23 Nabisco Brands, Inc. Nutritional athletic bar
US4687782A (en) * 1984-12-10 1987-08-18 Nutri-Fuels Systems, Inc. Nutritional composition for enhancing skeletal muscle adaptation to exercise training
US5039704A (en) * 1985-09-12 1991-08-13 Brigham And Women's Hospital Method of treating catabolic dysfunction
US5438042B1 (en) * 1993-10-08 1997-08-26 Sandoz Nutrition Ltd Enteral nutritional composition having amino acid profile
DE4343593C2 (en) * 1993-12-21 1998-05-20 Asta Medica Ag Use of R - (+) - alpha-lipoic acid, R - (-) - dihydrolipoic acid or the metabolites, and the salts, esters, amides for treating compensated and decompensated insulin resistance
US5536506A (en) * 1995-02-24 1996-07-16 Sabinsa Corporation Use of piperine to increase the bioavailability of nutritional compounds
US5856149A (en) * 1995-06-01 1999-01-05 Wisconsin Alumni Research Foundation Method of producing conjugated fatty acids
EP0854712B1 (en) * 1995-10-11 2003-05-07 Avicena Group, Inc. Use of creatine analogues for the treatment of disorders of glucose metabolism
US5944012A (en) * 1996-03-25 1999-08-31 Pera; Ivo E. Method for dispensing antioxidant vitamins by inhalation background of the invention
US5756469A (en) * 1996-07-26 1998-05-26 Beale; Paxton K. Composition of pyruvate and anti-cortisol compounds and method for increasing protein concentration in a mammal
US5976568A (en) * 1997-02-21 1999-11-02 Medical Doctors' Research Institute, Inc. Modular system of dietary supplement compositions for optimizing health benefits and methods
US5817329A (en) * 1997-02-28 1998-10-06 Gardiner; Paul T. Nutritional supplement for increased muscle size and strength for body builders
US6224871B1 (en) * 1998-03-11 2001-05-01 Reliv International, Inc. Dietary supplement for nutritionally promoting healthy joint function
US6136339A (en) * 1998-08-21 2000-10-24 Gardiner; Paul T. Food supplements and methods comprising lipoic acid and creatine
US6139339A (en) * 1999-08-09 2000-10-31 Hon Hai Precision Ind. Co., Ltd. Compact flash card connector

Cited By (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7169279B2 (en) 1998-09-14 2007-01-30 Applera Corporation Sample handling system for a multi-channel capillary electrophoresis device
US8603546B2 (en) * 1999-01-11 2013-12-10 Herbaceuticals Inc. Herbal supplement for increased muscle strength and endurance for athletes
US20040197320A1 (en) * 1999-01-11 2004-10-07 Herbaceuticals Inc. Herbal supplement for increased muscle strength and endurance for athletes
US20040234626A1 (en) * 1999-10-18 2004-11-25 Gardiner Paul T. Food supplement for increasing lean mass and strength
US7795204B2 (en) * 1999-10-18 2010-09-14 Northern Innovations And Formulations Corp. Food supplement for increasing lean mass and strength
US20040175443A1 (en) * 1999-10-18 2004-09-09 Gardiner Paul T. Food supplement for increasing lean mass and strength
WO2002009534A3 (en) * 2000-07-27 2003-10-09 Udo Apfelbaum Diatetisches lebensmittel zum fettabbau
US20040052926A1 (en) * 2000-07-27 2004-03-18 Udo Apfelbaum Dietetic food for breaking down fat
WO2002009534A2 (en) * 2000-07-27 2002-02-07 Sportmedizin Team Vertriebs Gmbh Diatetisches lebensmittel zum fettabbau
WO2002096218A2 (en) * 2001-05-28 2002-12-05 Basf Aktiengesellschaft Combination of lipoic acids, carnitines, and creatines in food and pharmaceuticals
WO2002096218A3 (en) * 2001-05-28 2003-05-01 Basf Ag Combination of lipoic acids, carnitines, and creatines in food and pharmaceuticals
WO2004017979A2 (en) * 2002-08-16 2004-03-04 Finzelberg Gmbh & Co. Kg Medicament, food supplement, and fodder additive
WO2004017979A3 (en) * 2002-08-16 2004-04-22 Finzelberg Gmbh & Co Kg Medicament, food supplement, and fodder additive
US7074418B2 (en) 2002-11-18 2006-07-11 Changaris David G Conjugated fatty acid based emulsion and methods for preparing and using same
US20040096468A1 (en) * 2002-11-18 2004-05-20 Changaris David G. Conjugated fatty acid based emulsion and methods for preparing and using same
US20040229950A1 (en) * 2002-11-26 2004-11-18 Vanderhoek Jack Y. Method and composition with conjugated linoleic acid esters
WO2004089114A1 (en) * 2003-04-14 2004-10-21 Cognis Ip Management Gmbh Preparations for oral administration containing physiologically active fatty acids and oligomer proanthocyanidin
JP2011184449A (en) * 2003-05-27 2011-09-22 Dsm Ip Assets Bv Novel nutraceutical composition and use thereof
EP2218342A3 (en) * 2003-05-27 2011-01-05 DSM IP Assets B.V. Novel nutraceutical compositions and use thereof
US8193240B2 (en) * 2004-03-17 2012-06-05 Nestec S.A. Compositions and methods for reducing or preventing obesity
US8883192B2 (en) * 2004-03-17 2014-11-11 Nestec S.A. Compositions and methods for reducing or preventing obesity
US20050222050A1 (en) * 2004-03-17 2005-10-06 Nestec S.A. Compositions and methods for reducing or preventing obesity
US20120270814A1 (en) * 2004-03-17 2012-10-25 Yuanlong Pan Compositions and methods for reducing or preventing obesity
WO2006015774A1 (en) * 2004-08-06 2006-02-16 Bioghurt Biogarde Gmbh & Co. Kg Physiologically acceptable composition containing alpha-lipoic acid, creatine, and a phosphatide
WO2006026458A2 (en) * 2004-08-25 2006-03-09 Mtor Formulations Ltd. Compositions and methods for activating protein synthesis and deactivating catabolic processes in skeletal muscle
US20060045906A1 (en) * 2004-08-25 2006-03-02 Gardiner Paul T Compositions and methods for activating protein synthesis and deactivating catabolic processes in skeletal muscle
WO2006026458A3 (en) * 2004-08-25 2006-05-11 Paul T Gardiner Compositions and methods for activating protein synthesis and deactivating catabolic processes in skeletal muscle
JP2008510494A (en) * 2004-08-25 2008-04-10 マルチ・フォーミュレーションズ・リミテッド Compositions and methods for inactivation and protein synthesis of catabolic processes in the skeletal muscle
US20060251727A1 (en) * 2005-04-11 2006-11-09 Gardiner Paul T Supplemental dietary composition for increasing muscle size, strength, athletic performance and/or exercise capacity
US20090220626A1 (en) * 2005-10-06 2009-09-03 Nicogen Imc. Grape seed extract and its constituents for use as cyp2a6 inhibitors
EP1774973A1 (en) * 2005-10-12 2007-04-18 Nutricia N.V. Leucine rich composition
US20080275120A1 (en) * 2005-10-12 2008-11-06 N.V. Nutricia Leucine rich composition
US9427002B2 (en) 2005-11-02 2016-08-30 Nestec S.A. Isoflavone compositions for reducing accumulation of body fat in male mammals, and methods for their use
US8226973B2 (en) 2005-11-02 2012-07-24 Nestec, S. A. Isoflavone compositions for reducing accumulation of body fat in male mammals, and methods for their use
US20070110789A1 (en) * 2005-11-02 2007-05-17 Nestec, S. A. Isoflavone compositions for reducing accumulation of body fat in male mammals, and methods for their use
EP1954262A2 (en) * 2005-11-07 2008-08-13 Perque, LLC. Compositions for regulating metabolic disorders and methods of use thereof
EP1954262A4 (en) * 2005-11-07 2012-05-02 Russell M Jaffe Compositions for regulating metabolic disorders and methods of use thereof
JP2007308468A (en) * 2006-05-18 2007-11-29 Bhn Kk Basal metabolism increasing agent
US20100080856A1 (en) * 2008-09-26 2010-04-01 Costantino Peter D Method and composition for postoperative wound healing
WO2011022786A1 (en) * 2009-08-31 2011-03-03 Pharmaqest Pty Ltd Methods for diagnosis and treatment of chronic fatigue syndrome
GB2479748A (en) * 2010-04-20 2011-10-26 Sis Carnitine containing nutritional composition
KR101695299B1 (en) * 2010-10-11 2017-01-11 (주)아모레퍼시픽 Composition for preventing or treating obesity or hyperlipidemia containing Piper longum extract, soy extract containing isoflavon and L-carnitin
KR20120037145A (en) * 2010-10-11 2012-04-19 (주)아모레퍼시픽 Composition for preventing or treating obesity or hyperlipidemia containing piper longum extract, isoflavon and l-carnitin
GB2494409A (en) * 2011-09-06 2013-03-13 Ashley Mark Lawrence Vegan protein drink
CN103190630B (en) * 2013-04-19 2015-08-12 广东太阳神集团有限公司 The functional protein powder containing conjugated linoleic acid glycerides
CN103190630A (en) * 2013-04-19 2013-07-10 广东太阳神集团有限公司 Functional protein powder containing conjugated linoleic acid glycerides
GB2519965A (en) * 2013-11-01 2015-05-13 Readysupp Ltd Formulation
EP2926669A1 (en) 2014-04-02 2015-10-07 AlzChem AG Creatine protein matrix and method for manufacturing the same
WO2015150275A1 (en) 2014-04-02 2015-10-08 Alzchem Ag Creatine-protein matrix and method for producing said matrix

Also Published As

Publication number Publication date Type
US20040170709A1 (en) 2004-09-02 application
US8168241B2 (en) 2012-05-01 grant

Similar Documents

Publication Publication Date Title
Nielsen et al. Update on the relationship between magnesium and exercise
Maughan Role of micronutrients in sport and physical activity
US6579544B1 (en) Method for supplementing the diet
US6544547B2 (en) Nutritional composition containing methionine
US5484623A (en) Dietary system high in oil intake for the treatment of obesity and for the lowering of saturated fats
Coyle Fluid and fuel intake during exercise
US6261589B1 (en) Dietary supplement nutrient soft drink composition with psychoactive effect
US6413545B1 (en) Diet composition and method of weight management
US6159942A (en) Compositions for increasing energy in vivo
US5411757A (en) Palatable balanced amino acid-modified diet
US20050276839A1 (en) Appetite satiation and hydration beverage
US6652891B2 (en) Co-enzyme Q10 dietary supplement
US4687782A (en) Nutritional composition for enhancing skeletal muscle adaptation to exercise training
US5626849A (en) Weight loss composition for burning and reducing synthesis of fats
Balch Prescription for nutritional healing
US6429198B1 (en) Compositions for increasing athletic performance in mammals
Bucci Nutrients as ergogenic aids for sports and exercise
US6051236A (en) Composition for optimizing muscle performance during exercise
Applegate Effective nutritional ergogenic aids
Jäger et al. International society of sports nutrition position stand: protein and exercise
US6534480B2 (en) Compositions for increasing energy in vivo
US6784209B1 (en) Food supplement for increasing lean mass and strength
US20060280840A1 (en) Universal protein formulation meeting multiple dietary needs for optimal health and enhancing the human immune system
US5186963A (en) Therapeutic dietary composition containing amaranth
WO2006069918A1 (en) Use of infant formula with reduced protein content

Legal Events

Date Code Title Description
AS Assignment

Owner name: RELIV INTERNATIONAL, INC., MISSOURI

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HASTINGS, CARL W.;BARNES, DAVID J.;DALEY, CHRISTINE A.;REEL/FRAME:009722/0931

Effective date: 19981019